Clement Clarke International

What Clement Clarke International does

Clement Clarke International (CCI) is a UK-based medical device manufacturer with over 100 years of history (established 1923 per one source, 1917 per firmographics), specializing in respiratory disease diagnosis, monitoring, and treatment, with a distinctive focus on inhaler training techniques. Its core products include the Flo-Tone CR (a reusable training whistle that gives audible feedback when patients inhale at the correct flow rate for pMDI inhalers), the Able Spacer, and the A2A Spacer, all designed to help patients with asthma and COPD correctly administer inhaled medications. CCI's products are designed to work alongside pharmaceutical partners' inhaled medications, and the company has historically maintained strong relationships with major pharmaceutical companies that distribute spacer and training devices alongside their drug therapies.

CCI was acquired by Flexicare (Group) Limited on May 31, 2023, and now operates as a wholly-owned non-trading subsidiary within the Flexicare Group. Flexicare is a privately-held medical device company founded in 1989, headquartered in Mountain Ash, Wales, with operations across 15+ subsidiaries supporting healthcare professionals in 100+ countries. The broader group designs, manufactures, and supplies medical devices focused on airway management (ProVu Video Laryngoscopes, video stylets, supraglottic airways), respiratory therapy (VentiChamber, Veoflo Pro high flow nasal cannula), resuscitation (single-use and reusable manual resuscitators), and urology (Urimeter). CCI's products are now commercialized through Flexicare's direct sales force and global subsidiary network, reaching hospital systems, military medical forces, clinical skills labs, and individual clinicians. Group-level certifications include ISO 13485, UK MDR, LSAS, and MDSAP, and pricing is conducted via quote-based enterprise sales rather than public listing.

As a non-trading subsidiary, CCI has no independent revenue or operations; its strategic significance lies in its 100+ year brand heritage, established pharmaceutical relationships, and inhaler training product portfolio, which complement Flexicare's core airway management and respiratory franchises. The CCI sub-brand "Inhaler Training Techniques" remains a marketed line within Flexicare's broader product taxonomy.

Name

Clement Clarke International

Legal name

Clement Clarke International Limited

Website

https://clement-clarke.com

Company type

Private

Founded year

1923

Operating status

Acquired

Headcount range

101–250 employees

Short description

Clement Clarke International (CCI) is a UK medical device manufacturer with 100+ years of heritage, specializing in inhaler training devices (Flo-Tone CR, Able Spacer, A2A Spacer) that help asthma and COPD patients correctly use inhaled medications. Acquired by Flexicare Group in May 2023, it now operates as a non-trading subsidiary within Flexicare's global respiratory and airway management portfolio.

Ownership category

akta.pro rank

Product category

Respiratory Medical Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories) (HLAHAGAE)

akta.pro secondary industries

Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD), Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers) (HLAHAGAK)

Keywords

• Medical device manufacturing
• Inhaler training devices
• Respiratory care equipment
• Spacer devices
• Airway management solutions

Headquarters

HQ city

Köniz

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Device Sales: Designs, manufactures, and supplies medical devices with core focus on airway management and respiratory products. Products distributed globally through direct sales and subsidiaries.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Clement Clarke International (CCI) designs, manufactures, and supplies respiratory medical devices with a specialized focus on inhaler technique training and spacer devices. Its portfolio includes the Flo-Tone CR reusable training device and Able Spacer/A2A Spacer products that help asthma and COPD patients correctly use pressurized metered-dose inhaler (pMDI) medications. Following its May 2023 acquisition by Flexicare (Group) Limited, CCI operates as a non-trading subsidiary with its product lines integrated into Flexicare's global respiratory and airway management portfolio.

Product overview

Clement Clarke International (CCI), acquired by Flexicare in May 2023, is a UK medical device manufacturer with over 100 years of history specializing in respiratory disease diagnosis, monitoring, and treatment. CCI's core portfolio focuses on inhaler training techniques, including Flo-Tone CR (a reusable positive whistle training device), Able Spacer, and A2A Spacer products that help patients correctly use inhaled medications. As part of the Flexicare Group (a global medical device company with 40+ years of experience operating through 15+ subsidiaries across 100+ countries), CCI products complement Flexicare's broader offerings including airway management devices (ProVu Video Laryngoscopes, ProVu Video Stylets), respiratory products (VentiChamber, Veoflo Pro), urology solutions (Urimeter), and resuscitation equipment (Single-Use and Reusable Manual Resuscitators).

Differentiator

Problem solved

Functional benefit

Brands

• Inhaler Training Techniques: Product portfolio including Flo-Tone CR and related inhaler training devices that help patients use inhalers correctly

Products and services

• Clement Clarke International Inhaler Training Solutions A portfolio of patient-focused solutions supporting correct inhaler use and technique, developed by CCI and integrated into Flexicare's portfolio after the May 2023 acquisition. Designed to work alongside pharmaceutical company medications to help patients properly administer inhaled medications for asthma and COPD.
• Flo-Tone CR (Controlled Resistance) A reusable training device with a positive whistle that attaches to most aerosol inhaler mouthpieces. Provides audible feedback when patients inhale at the correct inspiratory flow rate, helping them learn proper inhaler technique for asthma and COPD management.
• Able Spacer A spacer device that helps patients effectively use inhaled medications by ensuring proper drug delivery to the lungs, used in conjunction with pMDI (pressurized metered-dose inhaler) medications.
• A2A Spacer A spacer device designed to improve inhaler technique and medication delivery for patients using pMDI inhalers for respiratory conditions such as asthma and COPD.

Named customers4 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered minor and core.

• Hydro WalesminorOthers · 22 April 2026Energy supply agreement for hydroelectric power from northern Wales to Flexicare's headquarters in southern Wales. Part of ESG agenda to reduce operational emissions and support long-term net-zero ambitions. Hydro Wales generates power from facilities originally built for slate mining operations.
• TruCorpcoreStrategic or Co-development Partner · 2 March 2025ProVu Video Laryngoscope integrated into TruCorp's TruGuide AI-guided intubation training package. This partnership enhances clinical training environments and supports clinicians beyond product delivery, extending Flexicare's presence in professional training settings.
• Rapidcare at Strode ParkminorChannel Partner/ Reseller/ DistributorSupply assistance partnership resulting in complete transitions to Flexicare product range, improving patient outcomes.
• Bamberger Akademien (Skills Lab)minorStrategic or Co-development PartnerCommitment to Skills Lab partnership in Germany has paved the way for future training using advanced simulators and monitoring equipment.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Drägerwerk: Dräger is a global leader in anaesthesia workstations, ventilators, and patient monitoring with overlapping products in anaesthesia delivery, breathing circuits, and airway accessories that compete with Flexicare's anaesthesia and ventilation portfolio.
• ResMed: ResMed is a global respiratory and sleep therapy incumbent with overlapping reach into oxygen therapy and connected inhaler adherence solutions (Propeller Health) that compete with CCI's inhaler-technique aids.
• Philips Respironics: Philips Respironics is a major incumbent in hospital and home respiratory care, including oxygen therapy and ventilation, competing across several of Flexicare/CCI's respiratory product categories with significantly larger R&D and clinical evidence resources.
• ICU Medical (Smiths Medical): ICU Medical, which now includes the former Smiths Medical portfolio, competes in airway management, resuscitation, and respiratory consumables with established global distribution comparable to Flexicare's.
• Fisher & Paykel Healthcare: Fisher & Paykel is a global leader in humidified high-flow oxygen therapy and respiratory humidification that competes with Flexicare's Veoflo Pro HFNC and ventilator humidification products, with much broader scale and clinical evidence.

Direct peers

• Intersurgical: Intersurgical is a European-based manufacturer of airway management, anaesthesia, and respiratory consumables with a broadly overlapping product portfolio (laryngeal masks, breathing circuits, resuscitators, filters) competing directly with Flexicare/CCI in hospitals across Europe and global export markets.
• Vyaire Medical: Vyaire Medical is a pure-play respiratory and anaesthesia device company selling ventilation, oxygen therapy, and airway products that compete head-to-head with Flexicare's Veoflo Pro HFNC, breathing filters, and resuscitation portfolio.
• Ambu A/S: Ambu is a global single-use medical device company with a strong airway management franchise (laryngeal masks, video laryngoscopes, bronchoscopes) directly competing with ProVu and Flexicare's single-use resuscitator and laryngoscope lines in anaesthesia and emergency care.
• Teleflex Life Sciences: Teleflex owns a major airway management portfolio (LMA laryngeal masks, endotracheal tubes, video laryngoscopy) that overlaps substantially with Flexicare/CCI's airway and anaesthesia product lines in hospitals worldwide.

Emerging players

• Adherium: Adherium is a digital health company focused on connected inhaler sensors and adherence monitoring, representing an emerging alternative to traditional spacer and whistle-based inhaler technique training aids like CCI's Flo-Tone CR and Able Spacer.

Market position

Weaknesses3 records

Competitive moat4 records

Key risks4 records

Customer concentration

• Xx.com/clement_clarke1
• LinkedInlinkedin.com/company/clement-clarke-international

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clement Clarke International